Lung cancer: the world's deadliest cancer The World Health Organization (WHO) reports lung cancer as the most common cause of cancer death in 2020. It is estimated to have caused 1.8 million deaths worldwide, 85% of which, were classified as non‐small cell lung cancers (NSCLC). Only 19% of patients diagnosed with NSCLC survive for longer than 5 years. This worryingly low figure reflects the difficulties in diagnosing early stages of lung cancer (~40% of NSCLC diagnoses made are already at...

Dr. Joanna Depciuch, who runs a lab in the Department of Functional Nanomaterials, based at the Institute of Nuclear Physics Polish Academy of Sciences (Krakow, Poland), is the proud owner of a CX-A. Joanna specializes in the synthesis of nanoparticles (NPs), particularly gold NPs (AuNPs), which hold great potential for a wide range of biomedical applications including diagnostics, drug delivery, and cancer treatment (1,2). Joanna kindly agreed to meet us to explain how she plans on using her...

Nanolive have been working in close collaboration with swiss-based biotech firm Idorsia for several years now. Idorsia, who specialize in the discovery, development, and commercialization of innovative small molecules, have been testing our automated microscope, the CX-A and our new quantitative software, EVE Analytics. We met with Dr. Urs Lüthi the Associate Director and Deputy Head of high throughput screening (HTS), and Alexandre Peter the Principal Scientific Associate to ask them for...